Aihara Y, Klein J
Max-Planck-Institut für Biologie, Abteilung Immungenetik, Tübingen, FRG.
Immunology. 1988 Mar;63(3):389-95.
We have produced hybridomas by the fusion of BALB/c (H-2d) bone marrow cells, bone marrow cells from BALB/c-nu/nu mice, BALB/c fetal liver cells, and BALB/c fetal thymocytes with the AKR (H-2k) thymoma BW5147. The hybridomas were selected for the expression of the Thy-1.2 antigen of the normal cell donor and for their ability to produce IL-2 upon co-culture with irradiated normal spleen cells. The hybridomas produce IL-2 when co-cultured with H-2k, H-2u, H-2j, or H-2v cells of some strains but not in mixtures with H-2p, H-2s, H-2f, H-2b, H-2q, or H-2d cells. An investigation into the nature of these differences revealed a novel type of interaction between hybridomas, mature T lymphocytes and class II-positive spleen or lymph node cells. The experiments described in this communication suggest that irradiated L3T4+, Ly-1 High T cells recognize syngeneic class II-positive spleen or lymph node cells, but only in some strains. The ability to recognize the syngeneic cells depends both upon the H-2 complex and on the non-H-2 genes. The recognition leads, in the absence of proliferation, to the secretion of an as yet unidentified and largely hypothetical factor which then acts on the hybridoma cells. Upon stimulation with the T lymphocyte-derived factor, the hybridoma cells begin to secrete IL-2, which can then be measured by the proliferation of the IL-2-dependent CTLL line. The IL-2 production by the hybridoma cells is independent of their proliferation. The described interaction apparently does not involve the T-cell receptor of the hybridoma cells. The interaction resembles the autoreactivity of thymocyte hybridomas described by other investigators, and therefore it is possible that this 'autoreactivity' may in fact be generated by a similar mechanism to the one described here.
我们通过将BALB/c(H-2d)骨髓细胞、BALB/c-nu/nu小鼠的骨髓细胞、BALB/c胎肝细胞和BALB/c胎胸腺细胞与AKR(H-2k)胸腺瘤BW5147融合,制备了杂交瘤。这些杂交瘤是根据正常细胞供体的Thy-1.2抗原表达以及与经辐照的正常脾细胞共培养时产生白细胞介素-2(IL-2)的能力来筛选的。当与某些品系的H-2k、H-2u、H-2j或H-2v细胞共培养时,杂交瘤会产生IL-2,但与H-2p、H-2s、H-2f、H-2b、H-2q或H-2d细胞混合时则不会产生。对这些差异本质的研究揭示了杂交瘤、成熟T淋巴细胞与II类阳性脾细胞或淋巴结细胞之间的一种新型相互作用。本通讯中描述的实验表明,经辐照的L3T4 +、Ly-1高表达T细胞能识别同基因的II类阳性脾细胞或淋巴结细胞,但仅在某些品系中如此。识别同基因细胞的能力既取决于H-2复合体,也取决于非H-2基因。这种识别在无增殖的情况下会导致分泌一种尚未鉴定且很大程度上是假设的因子,该因子随后作用于杂交瘤细胞。在用T淋巴细胞衍生因子刺激后,杂交瘤细胞开始分泌IL-2,然后可以通过IL-2依赖的CTLL细胞系的增殖来检测。杂交瘤细胞产生IL-2与其增殖无关。所描述的相互作用显然不涉及杂交瘤细胞的T细胞受体。这种相互作用类似于其他研究者描述的胸腺细胞杂交瘤的自身反应性,因此这种“自身反应性”实际上可能是由与本文所述类似的机制产生的。